Copyright
©The Author(s) 2015.
World J Gastroenterol. Jan 28, 2015; 21(4): 1275-1283
Published online Jan 28, 2015. doi: 10.3748/wjg.v21.i4.1275
Published online Jan 28, 2015. doi: 10.3748/wjg.v21.i4.1275
Figure 2 Stratified analysis of KRAS or BRAF status and overall survival.
Loge [adjusted hazard ratio (HR)] and 95%CI for BRAF and KRAS mutant tumors (vs wild-type tumors) in various strata are shown. A: KRAS mutant tumors; B: BRAF mutant tumors.
-
Citation: Kadowaki S, Kakuta M, Takahashi S, Takahashi A, Arai Y, Nishimura Y, Yatsuoka T, Ooki A, Yamaguchi K, Matsuo K, Muro K, Akagi K. Prognostic value of
KRAS andBRAF mutations in curatively resected colorectal cancer. World J Gastroenterol 2015; 21(4): 1275-1283 - URL: https://www.wjgnet.com/1007-9327/full/v21/i4/1275.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i4.1275